Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. Based in Doral, Florida, Zoolzy operates from a 3,684-square-foot facility. This move is part of ETST's strategy to seize opportunities that broaden its telehealth and pharmacy fulfillment platforms into complementary verticals.
The acquisition delivers value across three growth drivers: expanding overall profit margins, broadening access to new ingredients, and enabling entry into the veterinary market. By integrating Zoolzy's distribution capabilities, ETST's compounding pharmacies can secure essential raw materials at highly competitive wholesale pricing, significantly increasing profit margins. Additionally, the acquisition provides access to a wider range of ingredients, which can enhance the company's product offerings and flexibility in compounding.
One of the most notable implications of this acquisition is ETST's entry into the veterinary market. This new vertical presents a significant growth opportunity, as the demand for veterinary pharmaceuticals continues to rise. By leveraging Zoolzy's distribution network and FDA-approved products, ETST can tap into this market and diversify its revenue streams.
The acquisition also aligns with ETST's broader strategy to strengthen its position in the healthcare industry. As a holding company, ETST aims to build a integrated platform that combines telemedicine, pharmacy services, and now, pharmaceutical distribution. This vertical integration could lead to cost efficiencies and improved supply chain management, ultimately benefiting the company's bottom line.
Investors and industry observers view this acquisition as a positive step for ETST, as it not only enhances operational capabilities but also opens new avenues for growth. The company's move to expand into the veterinary sector could provide a competitive edge and increase its market share in the healthcare industry.
For more information on this acquisition and its implications, interested parties can access the full press release at https://ibn.fm/vcqkE and follow ETST's latest news at https://ibn.fm/ETST.
